MedDataX Logo

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

NCT ID: NCT07313384

Last Updated: 2025-12-31

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-15

Study Completion Date

2026-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Type 2 Diabetes Mellitus Obesity (Disorder)

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

GLP-1 Therapy Nutrition Support Obesity Weight loss therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GLP-1 Therapy

Individuals prescribed with GLP-1 Therapy for obesity or T2DM management.

GLP-1 Therapy

Intervention Type DRUG

Exposure to GLP-1 Therapy for obesity or T2DM management.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GLP-1 Therapy

Exposure to GLP-1 Therapy for obesity or T2DM management.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults aged 18 and older
* Recently has been prescribed GLP-1 therapy for the treatment of obesity or T2DM but have not yet initiated the medication
* Has regular access to a smartphone and internet to complete short surveys and food recalls online
* Willing to sign informed consent.

Exclusion Criteria

* Already began the GLP-1 medication
* Have medical concerns making participation unsafe
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of South Carolina

OTHER

Sponsor Role lead

Prisma Health-Upstate

OTHER

Sponsor Role collaborator

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shiba Simon Bailey

Posdoctoral Fellow

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University South Carolina

Columbia, South Carolina, United States

Site Status ENROLLING_BY_INVITATION

Prisma Health Weight Management Institute

Greenville, South Carolina, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

John D Scott, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2371702-1

Identifier Type: -

Identifier Source: org_study_id